Indications and uses
For use as a protectant against further irritation or to relieve dryness of the eye.
For use as a protectant against further irritation or to relieve dryness of the eye.
Shake well before using. Instill 1 or 2 drops in the affected eye(s) as needed and discard container.
Light Mineral Oil (0.5%)
Mineral Oil (0.5%)
Emollient
For use as a protectant against further irritation or to relieve dryness of the eye.
For use in the eyes only.
If swallowed, get medical help or contact a Poison Control Center immediately.
Cetrimonium Bromide, glycerin, poloxamer 188, tris hydrochloride, tromethamine, tyloxapol, water for injection.
Call (800) 233-5469 M-F 8:30AM-5:30PM CST
or visit
www.ocusoft.com
NDC 54799-917-30
OCuSOFT
®
MGD™
ADVANCED™
Lubricant Eye Drops
Non-Preserved*
Relieves Irritation
Long-Lasting Comfort
Superior Dry Eye Relief
Without A Prescription
30 Sterile
Single-Dose Vials
0.01 fl oz (0.4 mL) each
Retaine® MGD™ Advanced™ is
a non-preserved* ophthalmic
emulsion that delivers complete
Dry Eye relief utilizing a
proprietary oil in water emulsion
technology (microemulsification)
with electrostatic attraction to
restore the three layers of the
tear film without blurring.
Replenishes LIPID LAYER and
reduces tear evaporation
Adds moisture to AQUEOUS
LAYER
Lubricates and protects
MUCIN LAYER
*Cetrimonium bromide is a cationic
stabilizer and is not added as a
preservative.
Positively Charged
Retaine® MGD™
Droplets
Negatively Charged
Ocular Surface
Use only if twist top of
single-dose vial is intact.
OCuSOFT®
Manufactured for OCuSOFT LLC.
Rosenberg, TX 77471 USA
© 2025 OCuSOFT Inc.
www.ocusoft.com
Patents:
www.ocusoft.com/patents
All registered trademarks are property of
OCuSOFT Inc.

| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 77dc03a4-fbfc-e6a3-fe95-285bbae40d75 | Product name | 2 | 20250814 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 54799-917-30 | retaine MGD | 30 in 1 CONTAINER | EMULSION | 30 | 8 | |
| 54799-917-30 | retaine MGD | 0.4 mL in 1 VIAL, SINGLE-DOSE | EMULSION | 0.4 | 8 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 54799-917-30 | EA - Each | 54799-917 | 12a4c762-6f86-4c50-9420-d3d1bb150a9e | 1 | 2025-05-14 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| LIGHT MINERAL OIL | ACTIVE INGREDIENT | N6K5787QVP | 3 | |
| MINERAL OIL | ACTIVE INGREDIENT | T5L8T28FGP | 3 | |
| LIGHT MINERAL OIL | ACTIVE MOIETY | N6K5787QVP | 3 | |
| MINERAL OIL | ACTIVE MOIETY | T5L8T28FGP | 3 | |
| CETALKONIUM CHLORIDE | INACTIVE INGREDIENT | 85474O1N9D | 3 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 3 | |
| POLOXAMER 188 | INACTIVE INGREDIENT | LQA7B6G8JG | 3 | |
| TROMETHAMINE | INACTIVE INGREDIENT | 023C2WHX2V | 3 | |
| TROMETHAMINE HYDROCHLORIDE | INACTIVE INGREDIENT | 383V75M34E | 3 | |
| TYLOXAPOL | INACTIVE INGREDIENT | Y27PUL9H56 | 3 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 54799-917 | 54799-917-30 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Cetrimonium Bromide | L64N7M9BWR | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| POLOXAMER 188 | LQA7B6G8JG | IACT |
| TROMETHAMINE HYDROCHLORIDE | 383V75M34E | IACT |
| TROMETHAMINE | 023C2WHX2V | IACT |
| TYLOXAPOL | Y27PUL9H56 | IACT |
| WATER | 059QF0KO0R | IACT |
| LIGHT MINERAL OIL | N6K5787QVP | ACTIB |
| MINERAL OIL | T5L8T28FGP | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| TROMETHAMINE | TROMETHAMINE | 023C2WHX2V | SOLUTION/ DROPS / OPHTHALMIC | 0.8 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / OPHTHALMIC | 3 mg | ||
| TROMETHAMINE | TROMETHAMINE | 023C2WHX2V | SOLUTION, GEL FORMING / DROPS / OPHTHALMIC | 1 mg | ||
| TROMETHAMINE | TROMETHAMINE | 023C2WHX2V | SUSPENSION/ DROPS / OPHTHALMIC | ADJ PH | ||
| TYLOXAPOL | TYLOXAPOL | Y27PUL9H56 | SUSPENSION/ DROPS / OPHTHALMIC | 0.3 %w/v | ||
| TROMETHAMINE | TROMETHAMINE | 023C2WHX2V | SOLUTION / OPHTHALMIC | 0.75 %w/v | ||
| TYLOXAPOL | TYLOXAPOL | Y27PUL9H56 | SUSPENSION / OPHTHALMIC | 7 mg | ||
| TROMETHAMINE | TROMETHAMINE | 023C2WHX2V | SOLUTION/ DROPS / OPHTHALMIC | 0.8 %w/v | ||
| TYLOXAPOL | TYLOXAPOL | Y27PUL9H56 | SUSPENSION / OPHTHALMIC | 7 mg | ||
| POLOXAMER 188 | POLOXAMER 188 | LQA7B6G8JG | SOLUTION / OPHTHALMIC | 0.1 %w/v | ||
| TYLOXAPOL | TYLOXAPOL | Y27PUL9H56 | SOLUTION / OPHTHALMIC | 5 mg | ||
| TROMETHAMINE | TROMETHAMINE | 023C2WHX2V | SOLUTION, GEL FORMING, EXTENDED RELEASE / OPHTHALMIC | 0.8 %w/w | ||
| TROMETHAMINE | TROMETHAMINE | 023C2WHX2V | SOLUTION / OPHTHALMIC | 0.75 %w/v | ||
| TYLOXAPOL | TYLOXAPOL | Y27PUL9H56 | SUSPENSION/ DROPS / OPHTHALMIC | 0.3 %w/v | ||
| TROMETHAMINE | TROMETHAMINE | 023C2WHX2V | SUSPENSION/ DROPS / OPHTHALMIC | ADJ PH | ||
| TYLOXAPOL | TYLOXAPOL | Y27PUL9H56 | SOLUTION / OPHTHALMIC | 5 mg | ||
| POLOXAMER 188 | POLOXAMER 188 | LQA7B6G8JG | SOLUTION / OPHTHALMIC | 0.1 %w/v | ||
| TROMETHAMINE | TROMETHAMINE | 023C2WHX2V | SOLUTION, GEL FORMING / DROPS / OPHTHALMIC | 1 mg | ||
| TYLOXAPOL | TYLOXAPOL | Y27PUL9H56 | GEL / OPHTHALMIC | 0.05 %w/w | ||
| TROMETHAMINE | TROMETHAMINE | 023C2WHX2V | SOLUTION, GEL FORMING, EXTENDED RELEASE / OPHTHALMIC | 0.8 %w/w | ||
| TYLOXAPOL | TYLOXAPOL | Y27PUL9H56 | SOLUTION/ DROPS / OPHTHALMIC | 4 mg | ||
| TYLOXAPOL | TYLOXAPOL | Y27PUL9H56 | GEL / OPHTHALMIC | 0.05 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / OPHTHALMIC | 3 mg | ||
| TYLOXAPOL | TYLOXAPOL | Y27PUL9H56 | SOLUTION/ DROPS / OPHTHALMIC | 4 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| retaine MGD | MINERAL OIL | OCuSOFT LLC | 06f57d46-96c7-4093-84aa-874ff4b2131d | 2026-01-15 | Warnings | 54799-917-30 54799-917 54799091730 e5019f11-7124-4184-8481-8a1977cd186e 06f57d46-96c7-4093-84aa-874ff4b2131d |
Adverse event summaries are temporarily unavailable. Other product information remains available.